tenofovir has been researched along with Hypophosphatemia, Familial in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, TT; Gupta, SK; Ha, B; Kitch, DW; McComsey, GA; Melbourne, K; Morse, GD; Venuto, CS; Yeh, E | 1 |
| Bañón, S; Caballero, C; Casado, JL; Gomez, A; Moreno, S; Perez-Elías, MJ; Rey, JM; Rosillo, M; Santiuste, C; Vazquez, M | 1 |
| Bañón, S; Casado, JL; Del Rey, JM; Liaño, F; Moreno, A; Moreno, S; Perez-Elías, MJ; Rodriguez, M; Santiuste, C | 1 |
| Andrade, L; Libório, AB; Pereira, LV; Sanches, TR; Seguro, AC; Shimizu, MH | 1 |
1 trial(s) available for tenofovir and Hypophosphatemia, Familial
| Article | Year |
|---|---|
Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s.
Topics: Adult; Anti-HIV Agents; Bone Density; Dideoxynucleosides; Female; Glomerular Filtration Rate; Hip; HIV Infections; Humans; Hypophosphatemia, Familial; Male; Middle Aged; Phosphates; Spine; Tenofovir; Young Adult | 2017 |
3 other study(ies) available for tenofovir and Hypophosphatemia, Familial
| Article | Year |
|---|---|
Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
Topics: Absorptiometry, Photon; Adult; Aged; Anti-HIV Agents; Bone Density; Bone Resorption; Female; HIV Infections; Humans; Hypophosphatemia, Familial; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Tenofovir; Urinalysis | 2016 |
Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
Topics: Adult; Aged; Anti-HIV Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Hypophosphatemia, Familial; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome; Young Adult | 2016 |
Rosiglitazone reverses tenofovir-induced nephrotoxicity.
Topics: Adenine; Animals; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Hypoglycemic Agents; Hypophosphatemia; Hypophosphatemia, Familial; Kidney Diseases; Male; Membrane Transport Proteins; Organophosphonates; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Rosiglitazone; Tenofovir; Thiazolidinediones | 2008 |